Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Presant

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Blood|September 1, 1977
Prognostic significance of thrombocytosis in idiopathic sideroblastic anemiaR R Streeter, C A Presant, E Reinhard
Cancer Research|February 1, 1977
Biological characterization of a prolonged antileukemic effect of 5-azacytidineC A Presant, F Valeriote, T J Vietti
Cancer|February 1, 1976
Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumorsC A Presant, J F Kolhouse, C Klahr
Cancer|July 15, 1984
Iatrogenic superior vena cava syndrome. A new entityM Bertrand, C A Presant, L Klein, et al.
Cancer Treatment Reports|June 1, 1982
Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group reportA L Van Amburg, C A Presant, D Burns
Cancer|April 1, 1982
A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanomaC A Presant, A A Bartolucci, C Balch, et al.
Cancer Treatment Reports|March 1, 1984
Phase I study of continuous-infusion PALA and 5-FUB Ardalan, D Jamin, H N Jayaram, et al.
Cancer Treatment Reports|August 1, 1979
Phase II trial of piperazinedione in malignant melanoma: a report by the Southeastern Cancer Study GroupC A Presant, A A Bartolucci, P Ungaro, et al.
Cancer|June 15, 1984
Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanineC A Presant, A E Denes, C Liu, et al.
Journal of the National Cancer Institute|June 1, 1981
Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in miceC A Presant, D Coulter, F Valeriote, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Blood|September 1, 1977
Prognostic significance of thrombocytosis in idiopathic sideroblastic anemiaR R Streeter, C A Presant, E Reinhard
Cancer Research|February 1, 1977
Biological characterization of a prolonged antileukemic effect of 5-azacytidineC A Presant, F Valeriote, T J Vietti
Cancer|February 1, 1976
Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumorsC A Presant, J F Kolhouse, C Klahr
Cancer|July 15, 1984
Iatrogenic superior vena cava syndrome. A new entityM Bertrand, C A Presant, L Klein, et al.
Cancer Treatment Reports|June 1, 1982
Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group reportA L Van Amburg, C A Presant, D Burns
Cancer|April 1, 1982
A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanomaC A Presant, A A Bartolucci, C Balch, et al.
Cancer Treatment Reports|March 1, 1984
Phase I study of continuous-infusion PALA and 5-FUB Ardalan, D Jamin, H N Jayaram, et al.
Cancer Treatment Reports|August 1, 1979
Phase II trial of piperazinedione in malignant melanoma: a report by the Southeastern Cancer Study GroupC A Presant, A A Bartolucci, P Ungaro, et al.
Cancer|June 15, 1984
Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanineC A Presant, A E Denes, C Liu, et al.
Journal of the National Cancer Institute|June 1, 1981
Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in miceC A Presant, D Coulter, F Valeriote, et al.
Pageof 7